Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Primatene Mist CRL Underscores Challenges For OTC Asthma Treatments

Jan 04 2017

• By Malcolm Spicer

Related Content

Keeping Track: CDER 2016 Novel Approvals Hold At 22 As US FDA Declines Cempra's Solithera

Dec 30 2016

Merck Silence On OTC <em>Singulair</em> Speaks Volumes On Switch Outlook

Dec 11 2015

FDA Panel Votes Against Primatene Reboot Due To Safety Concerns

Feb 26 2014

Dry Powder Blows Dr. Natural OTC Epinephrine Inhaler Out Of Compliance

Mar 24 2016

Related Companies

Amphastar Pharmaceuticals, Inc.

Armstrong Medical Ltd.

Merck & Co., Inc.

Additional Topics

United States Drug Safety OTC Drugs Consumer Respiratory

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.